Medications

Bebtelovimab appears reliable for COVID-19 during Omicron epoch

For high-risk patients with mild-to-moderate COVID-19 during the Omicron epoch, bebtelovimab seems to be a reliable treatment option, according to a study published online Sept. 17 in the Journal of Infectious Diseases.

Diseases, Conditions, Syndromes

SARS-CoV-2 infections frequently asymptomatic in children

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are often asymptomatic among children, especially those aged 0 to 4 years, according to a study published online Aug. 31 in JAMA Network Open.

page 19 from 40